| JNP Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the JNP shares outstanding history going back to 8/9/2013:
Also see: JNP Market Cap History JNP YTD Return |
JNP Shares Outstanding History — Juniper Pharmaceuticals Share Count Over Time
As of 8/3/2018 Juniper Pharmaceuticals has 11.32 million JNP shares outstanding. Investors often track the JNP shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows JNP share count trends over time, with 22 historical shares outstanding datapoints presented, dating back to 8/9/2013.
| JNP Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||
JNP Historical Shares Outstanding: +0.66% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||
| JNP Stock Price Chart |
| About Juniper Pharmaceuticals Inc |
| Juniper Pharmaceuticals is healthcare company with core businesses consisting of its Crinone® (progesterone gel) franchise. Co. has two segments: product, which oversees the supply chain and manufacturing of Crinone®, an 8.0% progesterone bioadhesive vaginal gel designed for progesterone supplementation or replacement as part of an assisted reproductive technology treatment for infertile women with progesterone deficiency; and service, which includes pharmaceutical development, clinical trial manufacturing, and analytical and consulting services for Co.'s customers, as well as characterizing and developing pharmaceutical product candidates for Co.'s internal programs. We show 22 historical shares outstanding datapoints in our coverage of JNP's shares outstanding history. Understanding the changing numbers of JNP shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like JNP versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching JNP by allowing them to research JNP shares outstanding history as well as any other stock in our coverage universe. |
| JNP Current Stock Quote |
Quotes delayed 20 minutes  Free JNP Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| JNP Share Performance |
| Shares Outstanding Peers |
| Juniper Pharmaceuticals (JNP) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
JSPR Shares Outstanding History JUNS Shares Outstanding History JUPW Shares Outstanding History KA Shares Outstanding History KA Shares Outstanding History KALA Shares Outstanding History KALV Shares Outstanding History KDMN Shares Outstanding History KDNY Shares Outstanding History KEQU Shares Outstanding History More Healthcare companies » |
JNP Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
